Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rowe

Showing results (611-620 of 632) with videos related to

Pageof 64
Sort By:
The Prostate|January 12, 2023
Lack of repeatability of radiomic features derived from PET scans: Results from a <sup>18</sup> F-DCFPyL test-retest cohortRudolf A Werner, Bilêl Habacha, Susanne Lütje, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 20, 2021
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen-Targeted <sup>18</sup>F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or EnzalutamideKatherine A Zukotynski, Urban Emmenegger, Sebastien Hotte, et al.
BMC Cancer|July 1, 2017
A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)Noura Radwan, Ryan Phillips, Ashley Ross, et al.
The Journal of Urology|December 23, 2025
Performance of <sup>99m</sup>Tc-sestamibi SPECT/CT for Characterizing Renal Masses: Combined Results from a Prospective Scan-and-Resect Trial and Clinical ExperienceSteven P Rowe, Salikh Murtazaliev, Alireza Amindarolzarbi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 17, 2023
[<sup>18</sup>F]FNDP PET neuroimaging test-retest repeatability and whole-body dosimetry in humansYong Du, Jennifer M Coughlin, Alireza Amindarolzarbi, et al.
Molecular Imaging|March 14, 2022
High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with <sup>18</sup>F-DCFPyLRudolf A Werner, Bilêl Habacha, Susanne Lütje, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 13, 2015
¹⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate CancerSteven P Rowe, Kenneth L Gage, Sheila F Faraj, et al.
Nature Medicine|February 19, 2020
Dynamic imaging in patients with tuberculosis reveals heterogeneous drug exposures in pulmonary lesionsAlvaro A Ordonez, Hechuan Wang, Gesham Magombedze, et al.
Scientific Reports|January 16, 2024
Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinomaNirmish Singla, Thomas R Nirschl, Aleksandar Z Obradovic, et al.
Science Translational Medicine|December 7, 2018
Noninvasive <sup>11</sup>C-rifampin positron emission tomography reveals drug biodistribution in tuberculous meningitisElizabeth W Tucker, Beatriz Guglieri-Lopez, Alvaro A Ordonez, et al.
Pageof 64

Showing results (611-620 of 632) with videos related to

Sort By:
Pageof 64
The Prostate|January 12, 2023
Lack of repeatability of radiomic features derived from PET scans: Results from a <sup>18</sup> F-DCFPyL test-retest cohortRudolf A Werner, Bilêl Habacha, Susanne Lütje, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 20, 2021
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen-Targeted <sup>18</sup>F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or EnzalutamideKatherine A Zukotynski, Urban Emmenegger, Sebastien Hotte, et al.
BMC Cancer|July 1, 2017
A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)Noura Radwan, Ryan Phillips, Ashley Ross, et al.
The Journal of Urology|December 23, 2025
Performance of <sup>99m</sup>Tc-sestamibi SPECT/CT for Characterizing Renal Masses: Combined Results from a Prospective Scan-and-Resect Trial and Clinical ExperienceSteven P Rowe, Salikh Murtazaliev, Alireza Amindarolzarbi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 17, 2023
[<sup>18</sup>F]FNDP PET neuroimaging test-retest repeatability and whole-body dosimetry in humansYong Du, Jennifer M Coughlin, Alireza Amindarolzarbi, et al.
Molecular Imaging|March 14, 2022
High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with <sup>18</sup>F-DCFPyLRudolf A Werner, Bilêl Habacha, Susanne Lütje, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 13, 2015
¹⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate CancerSteven P Rowe, Kenneth L Gage, Sheila F Faraj, et al.
Nature Medicine|February 19, 2020
Dynamic imaging in patients with tuberculosis reveals heterogeneous drug exposures in pulmonary lesionsAlvaro A Ordonez, Hechuan Wang, Gesham Magombedze, et al.
Scientific Reports|January 16, 2024
Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinomaNirmish Singla, Thomas R Nirschl, Aleksandar Z Obradovic, et al.
Science Translational Medicine|December 7, 2018
Noninvasive <sup>11</sup>C-rifampin positron emission tomography reveals drug biodistribution in tuberculous meningitisElizabeth W Tucker, Beatriz Guglieri-Lopez, Alvaro A Ordonez, et al.
Pageof 64